A detailed history of Parallel Advisors, LLC transactions in Landec Corp \Ca\ stock. As of the latest transaction made, Parallel Advisors, LLC holds 225 shares of LNDC stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
225
Holding current value
$0
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
N/A
225 New
225 $0
Q2 2023

May 20, 2024

BUY
N/A
225 New
225 $0
Q2 2023

Aug 04, 2023

BUY
N/A
225 New
225 $0
Q3 2020

Oct 27, 2020

SELL
$7.59 - $10.8 $743 - $1,058
-98 Closed
0 $0
Q2 2020

Jul 16, 2020

BUY
$7.96 - $11.54 $780 - $1,130
98 New
98 $0

Others Institutions Holding LNDC

About LANDEC CORP \CA\


  • Ticker LNDC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,595,600
  • Description
  • Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...
More about LNDC
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.